Local inflammation occurs before systemic inflammation in patients with COPD

Respirology

Volumn 15, Issue 3, 2010, Pages 478-484

  He, Zhihui ^a   Chen, Yan ^a   Chen, Ping ^a   Wu, Guobao ^a   Cai, Shan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Blood; Chronic obstructive pulmonary disease; Inflammation; Sputum

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; ARTICLE; CELL COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; INFLAMMATION; INFLAMMATORY CELL; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT INFLAMMATION; SMOKING; SPUTUM LEVEL;

ADULT; AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; MIDDLE AGED; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SPUTUM;

EID: 77950244148     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2010.01709.x     Document Type: Article

References (33)

1. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 2004 23 : 932 946.
2. Asia Pacific COPD Roundtable Group. Global initiative for chronic obstructive lung disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: an Asia-Pacific perspective. Respirology 2005 10 : 9 17.
3. Djukanovic R, Roche WR, Wilson JW et al. Mucosal inflammation in asthma. Am. Rev. Respir. Dis. 1990 142 : 434 457.
4. Karadag F, Karul AB, Cildag O et al. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD. Lung 2008 186 : 403 409.
5. Gan WQ, Man SF, Senthilselvan A et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004 59 : 574 580.
6. Agusti AG, Noguera A, Sauleda J et al. Systemic effects of chronic obstructive pulmonary disease. Eur. Respir. J. 2003 21 : 347 360.
7. Barnes PJ, Stockley RA. COPD: current therapeutic interventions and future approaches. Eur. Respir. J. 2005 25 : 1084 1106.
8. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur. Respir. J. Suppl. 2001 34 : 50s 9s.
9. Gould JM, Weiser JN. Expression of c-reactive protein in the human respiratory tract. Infect. Immun. 2001 69 : 1747 1754.
10. Dupuy AM, Terrier N, Senecal L et al. [Is c-reactive protein a marker of inflammation?]. Nephrologie 2003 24 : 337 341.
11. Rabe KF, Hurd S, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: gold executive summary. Am. J. Respir. Crit. Care Med. 2007 176 : 532 555.
12. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997 277 : 925 926.
13. Peng H, Chen P, Cai S. [The change of concentration of endothelin derived from alveolar macrophages and in induced sputum in patients with chronic bronchitis]. Zhonghua Jie He He Hu Xi Za Zhi 2001 24 : 351 354.
14. Tsoumakidou M, Tzanakis N, Siafakas NM. Induced sputum in the investigation of airway inflammation of COPD. Respir. Med. 2003 97 : 863 871.
15. Bhowmik A, Seemungal TA, Sapsford RJ et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000 55 : 114 120.
16. Snoeck-Stroband JB, Postma DS, Lapperre TS et al. Airway inflammation contributes to health status in COPD: a cross-sectional study. Respir. Res. 2006 7 : 140.
17. Lapperre TS, Willems LN, Timens W et al. Small airways dysfunction and neutrophilic inflammation in bronchial biopsies and bal in COPD. Chest 2007 131 : 53 9.
18. Chen Y, Chen P, Hanaoka M et al. Enhanced levels of prostaglandin e2 and matrix metalloproteinase-2 correlate with the severity of airflow limitation in stable COPD. Respirology 2008 13 : 1014 1021.
19. Biffl WL, Moore EE, Moore FA et al. Interleukin-6 delays neutrophil apoptosis. Arch. Surg. 1996 131 : 24 9. discussion 9-30.
20. Bucchioni E, Kharitonov SA, Allegra L et al. High levels of interleukin-6 in the exhaled breath condensate of patients with COPD. Respir. Med. 2003 97 : 1299 1302.
21. Volanakis JE. Human c-reactive protein: expression, structure, and function. Mol. Immunol. 2001 38 : 189 197.
22. Pinto-Plata VM, Mullerova H, Toso JF et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 2006 61 : 23 8.
23. Karadag F, Kirdar S, Karul AB et al. The value of c-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Eur. J. Intern. Med. 2008 19 : 104 108.
24. Bircan A, Gokirmak M, Kilic O et al. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection. Med. Princ. Pract. 2008 17 : 202 208.
25. Donaldson GC, Seemungal TA, Patel IS et al. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005 128 : 1995 2004.
26. Eid AA, Ionescu AA, Nixon LS et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001 164 : 1414 1418.
27. Agusti AG. Systemic effects of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2005 2 : 367 370. discussion 71-2.
28. Langen RC, Korn SH, Wouters EF. Ros in the local and systemic pathogenesis of COPD. Free. Radic. Biol. Med. 2003 35 : 226 235.
29. Mukae H, Hogg JC, English D et al. Phagocytosis of particulate air pollutants by human alveolar macrophages stimulates the bone marrow. Am. J. Physiol. Lung Cell Mol. Physiol. 2000 279 : L924 31.
30. Vernooy JH, Kucukaycan M, Jacobs JA et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am. J. Respir. Crit. Care Med. 2002 166 : 1218 1224.
31. Takabatake N, Nakamura H, Abe S et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2000 161 : 1179 1184.
32. Yanbaeva DG, Dentener MA, Creutzberg EC et al. Systemic inflammation in copd: is genetic susceptibility a key factor? COPD 2006 3 : 51 61.
33. Yanbaeva DG, Dentener MA, Spruit MA et al. Il6 and crp haplotypes are associated with copd risk and systemic inflammation: a case-control study. BMC Med. Genet. 2009 10 : 23.